Volume 11, Number 10—October 2005
Letter
Angiostrongyliasis, Mainland China
Table
Characteristics | Outbreak 1 (%) | Outbreak 2 (%) |
---|---|---|
No. of patients | 47 | 8 |
No. of male patients (%) | 24 (51) | 8 (100) |
Age, y | ||
Median | 32 | 12 |
Range | 6–58 | 11–13 |
Incubation (day) | ||
Median | 10.35 | 6 |
Range | 1–27 | 5–7 |
Symptoms†, no. (%) | ||
Headache | 44 (93.6) | 8 (100) |
Nuchal rigidity or neck pain | 0 | 6 (75.0) |
Fatigue | 7 (14.9) | 7 (87.5) |
Vomiting | 9 (19.1) | 8 (100) |
Paresthesias | 30 (63.8) | 3 (37.5) |
Muscle pain | 43 (91.5) | 8 (100) |
Fever | 27 (57.4) | 3 (37.5) |
Cough | 4 (8.5) | 0 |
Somnolence | 4 (8.5) | 7 (87.5) |
Skin eruption | 10 (21.3) | 0 |
Skin itch | 13 (27.7) | 0 |
Laboratory detection No. positive/no. examined (%) | ||
Eosiniphils in cerebrospinal fluid | 23/25 (92) | 8/8 (100) |
Eosinophils in blood | 23/25 (92) | 8/8 (100) |
Serologic diagnosis | 21/25 (84) | NT |
Pathogenic test | ND | 1/8‡ (12.5) |
*NT, not tested; ND, not detected.
†No patients had visual disturbance or photophobia, hyperesthesias, muscle weakness, or diarrhea.
‡Two larvae were found in cerebrospinal fluid.
Page created: February 21, 2012
Page updated: February 21, 2012
Page reviewed: February 21, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.